Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis
about
MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?Expanding the indications for MRI in the diagnosis and treatment of breast cancer: what is best practice?A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.Imaging-based screening: understanding the controversies.Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules.Genetics of breast cancer: a topic in evolution.Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriersBreast Cancer Screening for High-Risk Patients of Different Ages and Risk - Which Modality Is Most Effective?Familial pancreatic cancer: Concept, management and issues.The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer: where are we now?Hereditary breast cancer syndromes and genetic testing.The role of dynamic contrast-enhanced screening breast MRI in populations at increased risk for breast cancer.Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.Breast fine-needle aspiration cytology performance in the high-risk screening population: a study of BRCA1/BRCA2 mutation carriers.Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.Genetics of pancreatic cancer and implications for therapy.Attitudinal concordance toward uptake and disclosure of genetic testing for cancer susceptibility in patient-family member dyads.
P2860
Q26785571-D6C2FD91-8F0E-4B3C-903B-0498236ACEE2Q26801072-14D09280-C732-4E9A-90FF-4B05BEFFBB08Q34097351-0AC52544-9181-41A6-B426-3E780D0C1FAEQ34452684-168D5AD0-05B1-42E7-86D4-A4674621B236Q35118758-5A288A0F-BACC-45FD-AFD8-7E779268A9D2Q35122658-EB75660C-0FF6-4D78-8A6B-83C9337329DCQ35775223-468B2007-4BB6-45DD-98DD-4C709BE5828CQ36652732-0E79EB6D-C497-4316-BB5F-30E76E348E0EQ37608651-1502F9BA-BA27-46CB-81A0-25333C086070Q37644011-22AA4E04-DF54-43CB-90D5-7193C004FB19Q38154495-1CA8843D-6D95-4BA6-8237-BECBB413E143Q38266306-BABC05C7-9775-4F3C-93A0-07C4AFAAEE5EQ38284365-9C48BB7F-4961-41C2-BEF5-C615A315CD06Q38812876-133A5C6F-A384-4F91-9746-8E4B0FB74B45Q43639185-D0295A5D-D146-4E37-B1D5-C8B0FC11D7B5Q46135272-C21D87A5-5327-40A5-A4A8-7F87DB6E9B59Q49606173-4B4890C6-4170-4D1E-8D0D-EB4DA743095BQ53301101-7207C370-C5F3-4CD5-AE7E-27E66B9891AE
P2860
Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Annual screening strategies in ...... arative effectiveness analysis
@ast
Annual screening strategies in ...... arative effectiveness analysis
@en
type
label
Annual screening strategies in ...... arative effectiveness analysis
@ast
Annual screening strategies in ...... arative effectiveness analysis
@en
prefLabel
Annual screening strategies in ...... arative effectiveness analysis
@ast
Annual screening strategies in ...... arative effectiveness analysis
@en
P2093
P2860
P356
P1433
P1476
Annual screening strategies in ...... arative effectiveness analysis
@en
P2093
Chung Y Kong
Constantine Gatsonis
Elissa M Ozanne
Etta D Pisano
G Scott Gazelle
Janie M Lee
Jessica E Cott Chubiz
Kathryn P Lowry
Michael E Gilmore
Paula D Ryan
P2860
P304
P356
10.1002/CNCR.26424
P407
P577
2011-09-20T00:00:00Z